![\"\"](\"https:\/\/www.novogene.com\/us-en\/wp-content\/uploads\/sites\/4\/2022\/03\/tp1.png\")
<\/p>\nRecently, PacBio officially announced that Novogene had been listed as ” PacBio Certified Service Provider,\u201d which indicates that Novogene has the ability to provide global customers with higher quality, more innovative, more accurate, and more affordable third-generation sequencing services.<\/p>\n
<\/p>\n
The PacBio Certified Service Provider Program is a worldwide network of authentic service organizations that use next-generation sequencing innovation and technology. Certified providers are subject to a regulated certification process to provide them with the most current training on PacBio sample capabilities and data analysis processes. The certification will offer Novogene a decisive advantage, helping it instil a higher level of confidence and trust that its customers will receive top-notch genetic analysis and genomic services utilizing PacBio tech. <\/p>\n
![\"\"](\"https:\/\/www.novogene.com\/us-en\/wp-content\/uploads\/sites\/4\/2022\/03\/gwjt.png\")
<\/p>\n
Shen Shichao, our general manager of business delivery of Novogene, said: “PacBio Sequel IIe is one of the most powerful platforms for single-molecule real-time (SMRT) sequencing, and the certification of PacBio once again proves Novogene’s excellent sequencing service capabilities. We have established a complete third-generation sequencing service system and adhered to the strict implementation of experimental operation specifications to ensure the accuracy and reproducibility of the final sequencing results, to provide innovative and high-quality scientific research and clinical research sequencing services on a global scale.”<\/p>\n
Since the launch of the third-generation sequencing service in 2017, Novogene has completed sequencing of more than 1,300 species through the PacBio platform, accumulating a lot of sequencing and analysis experience; In the field of complex samples, we continue to overcome experimental difficulties and innovate methods for nucleic acid preparation and library optimization for different species and have applied for a patent. <\/p>\n
According to statistics, Novogene and scientists worldwide have published several research results in high-level international journals such as Science, Nature Genetics, Nature Plants, and Nature Communications using the PacBio platform. The cumulative impact factor of the project is 600+. At the same time, more than ten copyrights of data analysis software have been obtained.<\/p>\n
As the world’s leading provider of gene sequencing products and services, Novogene has advanced and comprehensive second-generation sequencing, third-generation sequencing, and multi-omics platforms to meet the diverse needs of global customers and be a “reliable partner.\u201d<\/p>\n